Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC

Brain Research

Volumn 850, Issue 1-2, 1999, Pages 207-216

  Ekinci, Fatma J ^a   Shea, Thomas B ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Alzheimer's disease; Calpain; MAP kinase; Paired helical filaments; Protein kinase C; Protein kinase M phosphorylation; Signal transduction; Tau

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIMYCIN; DIACYLGLYCEROL; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TAU PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBUNIT; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

AUTORADIOGRAPHY; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIMYCIN; CALPAIN; CATALYSIS; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DENSITOMETRY; ENZYME ACTIVATORS; ENZYME INHIBITORS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASE C; TAU PROTEINS; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0032733910     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02146-0     Document Type: Article

References (79)

1. Adamec E., Mercken M., Beermann M.L., Didier M., Nixon R.A. Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau. Brain Res. 757:1997;93-101.
2. Al Z., Cohen C.M. Phorbol 12-myristate 13-acetate-stimulated phosphorylation of erythrocyte membrane skeletal proteins is blocked by calpain inhibitors: possible role of protein kinase M. Biochem. J. 296:1993;675-683.
3. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seiteberger F., Grundke-Iqbal I., Iqbal I., Wisniewski H.M. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99.
4. Bartus R.T. The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway. Neuroscientist. 3:1997;314-327.
5. Boyce J.J., Shea T.B. Phosphorylation events mediated by protein kinase Cα and ε participate in the regulation of tau steady-state levels and generation of certain "Alzheimer-like" phospho-epitopes. Int. J. Dev. Neurosci. 15:1997;295-307.
6. Brambett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M.-Y. Abnormal tau phosphorylation at ser-396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 10:1993;1089-1099.
7. Combs C.K., Coleman P.D., O'Banion M.K. Developmental regulation and PKC dependence of Alzheimer's-type tau phosphorylations in cultured fetal rat hippocampal neurons. Dev. Brain Res. 107:1998;143-158.
8. Couratier P., Lesort M., Condamines O., Mourton-Gilles C., Delacourte A., Hugon J. Phorbol ester enhances phosphorylated tau protein immunoreactivity in neuronal cultures. Neurosci Lett. 203(3):1996;155-158. (1996 Jan. 26).
9. Cressman C.M., Shea T.B. Hyperphosphorylation of tau and filopodial retraction following microinjection of protein kinase C catalytic subunits. J. Neurosci. Res. 42:1995;648-656.
10. Cressman C.M., Mercken M.M., Shea T.B. Alteration in tau antigenicity and electrophoretic migration by PKCa under cell-free conditions. Neurosci. Res. Commun. 17:1995;61-64.
11. Cressman C.M., Mohan P.S., Nixon R.A., Shea T.B. Proteolysis of protein kinase C: mM, μM-requiring calpains have different abilities to generate, and degrade, the free catalytic subunit, protein kinase M. FEBS Lett. 367:1995;223-227.
12. Ekinci F.J., Shea T.B. Selective activation by bryostatin demonstrates unique roles for PKCe in neurite extension and tau phosphorylation. Int. J. Dev. Neurosci. 15:1997;867-874.
13. Ekinci F.J., Shea T.B. Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: Additive and synergistic influence of alteration of additional kinase activities. Cell. Mol. Neurobiol. 19:1999;249-260.
14. Felipo V., Minana M.-D., Grisola S. A specific inhibitor of protein kinase C induces differentiation of neuroblastoma cells. J. Biol. Chem. 265:1990;9599-9601.
15. Fleming L.M., Johnson G.V. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem. J. 309:1995;41-47.
16. Franklin, Kraft A.S. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells. Oncogene. 11:1995;2365-2374.
17. Goedert M., Jakes R., Crowther R.A., Six J., Lubke U., Vandermeeren M., Cras P., Trojanowski J.Q., Lee V.M.-Y. The abnormal phosphorylation of tau proteins at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. USA. 90:1993;5066-5070.
18. Goedert M., Spillantini M.G., Jakes R., Crowther R.A., Vandermeeren M., Probst A., Gotz J., Burki K., Cohen P. Molecular dissection of the paired helical filament. Neurobiol. Aging. 16:1995;325-334.
19. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 409:1997;57-62.
20. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localization of the kinase. Neurosci. Lett. 147:1992;58-62.
21. Hashimoto K., Kishimoto A., Aihara H., Yasuda I., Mikawa K., Nishizuka Y. Protein kinase C during differentiation of human promyelocytic leukemia cell line, HL-60. FEBS Lett. 263:1990;31-34.
22. Heikkila J.E., Akerlind G., Akerman K.E.O. Protein kinase C activation and down-regulation in relation to phorbol ester-induced differentiation of SH-SY-5Y human neuroblastoma. J. Cell. Physiol. 140:1991;593-600.
23. Ho D.T., Shayan H., Murphy T.H. Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation. J. Neurochem. 68:1997;106-111.
24. Hong M., Lee V.M.-Y. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272:1997;19547-19553.
25. Hong M., Chen D.C., Klein P.S., Lee V.M. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272:1997;25326-25332.
26. Inoue M., Kishimoto A., Takai Y., Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues: II. Proenzyme and its activation by calcium-dependent protease from rat brain. J. Biol. Chem. 252:1977;7610-7616.
27. Jicha G.A., O'Donnell A., Weaver C., Angeletti R., Davies P. Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase. J. Neurochem. 72:1999;214-224.
28. Kishimoto A., Kajikawa N., Shiota M., Nishizuka Y. Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J. Biol. Chem. 258:1983;1156-1164.
29. Kishimoto A., Mikawa K., Hashimoto K., Yasuda I., Tanaka S., Tominaga M., Kuroda T., Nishizuka Y. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J. Biol. Chem. 264:1989;4088-4092.
30. Kobayashi S., Ishiguro K., Omori A., Takamatsu M., Arioka M., Imahora K., Uchida T. A cdc-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed kinase associated with microtubules. FEBS Lett. 335:1993;171-175.
31. Koh J.-Y., Yang L.L., Cotman C.W. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
32. Lang D., Beermann M.L., Hauser G., Cressman C.M., Shea T.B. Phospholipids inhibit proteolysis of protein kinase C alpha by mM calcium-requiring calpain. Neurochem. Res. 20:1995;1361-1364.
33. Lanius R.A., Paddon H.B., Mezei M., Wagey R., Krieger C., Pelech S.L., Shaw C.A. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J. Neurochem. 65:1995;927-930.
34. Latimer D.A., Gallo J.M., Lovestone S., Miller C.C., Reynolds C.H., Marquardt B., Stabel S., Woodgett J.R., Anderton B.H. Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau. FEBS Lett. 365(1):1995;42-46. (1995 May 22).
35. Leli U., Cataldo A.M., Shea T.B., Nixon R.A., Hauser G. Distinct mechanisms of differentiation of SH-SY-5Y neuroblastoma cells by protein kinase C activators and inhibitors. J. Neurochem. 58:1992;1191-1198.
36. Leli U., Parker P.J., Shea T.B. Intracellular delivery of protein kinase C-α or -ε isoform-specific antibodies promotes acquisition of a morphologically differentiated phenotype in neuroblastoma cells. FEBS Lett. 297:1992;91-94.
37. Lovestone S., Reynolds C.H., Latimer D., Davis D.R., Anderton B.H., Gallo J.M., Hanger D., Mulot S., Marquardt B., Stabel S. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3β in transfected mammalian cells. Curr. Biol. 4:1994;1077-1086.
38. Lu Q., Soria J.P., Wood J.G. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. J. Neurosci. Res. 35:1993;439-444.
39. Mandelkow E.-M., Mandelkow E. Tau in Alzheimer's disease. Trends in Cell. Biol. 8:1998;425-427.
40. Mattson M.P. Evidence for the involvement of protein kinase C in neurodegenerative changes in cultured human cortical neurons. Exp. Neurol. 16:1991;95-103.
41. 2+ homeostasis in Alzheimer's disease. Trends Neurol. Sci. 16:1993;409-414.
42. Minana M.-D., Felipo V., Grisolia S. Inhibition of protein kinase C induces differentiation of neuroblastoma cells. FEBS Lett. 87:1989;184-186.
43. Munoz-Montano J.R., Moreno F.J., Avila J., Diaz-Nido J. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411:1995;183-188.
44. Murray A.W., Fournier A., Hardy S.J. Proteolytic activation of protein kinase C: a physiological reaction? TIBS. 12:1987;53-54.
45. Nixon R.A., Saito K.I., Grynspan F., Griffin W.R., Katayama S., Honda T., Mohan P.S., Shea T.B., Beermann M. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. NY Acad. Sci. 747:1994;77-91.
46. Norman S.G., Johnson G.V. Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices. Neurochem. Res. 19:1994;1151-1158.
47. Ono K., Katayama N., Yamagata Y., Tokunaga A., Tsuda M. Morphology of neurites from N18TG2 cell induced by protein kinase inhibitor H-7 and by cAMP. Brain Res. Bull. 26:1991;605-612.
48. Ono K., Tokunaga A., Tsuda M. Neurite outgrowth from N18TG2 neuroblastoma induced by H-7, a protein kinase inhibitor, in the presence of colchicine. Brain Res. Bull. 31:1993;209-215.
49. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
50. Parodi M.T., Varesio L., Tonini G.P. The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiaton of human neuroal crest-derived lineages. FEBS Lett. 269:1990;4-6.
51. Pontremoli S., Melloni E., Salamino F., Patrone M., Michetti M., Horecker B.L. Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe. Biochem. Biophys. Res. Commun. 160:1989;737-743.
52. Pontremoli S., Michetti M., Melloni E., Sparatore B., Salamino F., Horecker B.L. Identification of the proteolytically activated form of protein kinase C in stimulated human neutrophils. Proc. Natl. Acad. Sci. USA. 87:1990;3705-3707.
53. Pundreddy S., Shea T.B. AD-like tau phosphorylation in human neuroblastoma cells following PKC hyperactivation is mediated by MAP kinase. Neurosci. Res. Commun. 21:1997;173-177.
54. Reynolds C.H., Utton M., Gibb G.M., Yates A., Anderton B.H. Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J. Neurochem. 68:1997;1736-1744.
55. Reynolds C.H., Nebreda A.R., Gibb G.M., Utton M., Anderton B.H. Reactivating kinase/p38 phosphorylates tau protein in vitro. J. Neurochem. 69:1997;191-198.
56. Saito T., Ishiguro K., Uchida T., Miyamoto E., Kishimoto T., Hisanaga S. In situ dephosphorylation of tau by protein phosphatase 2A, 2B in fetal rat primary cultured neurons. FEBS Lett. 376:1995;238-242.
57. Sautiére P.-E., Caillet-Boudin M.-L., Wattez A., Delacourte A. Detection of Alzheimer-type tau proteins in okadaic acid-treated SKNSH-SY-5Y neuroblastoma cells. Neurodegeneration. 3:1994;53-60.
58. Sengupta A., Wu Q., Grundke-Iqbal I., Iqbal K., Singh T.J. Potentiation of GSK-3β-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell. Biochem. 167:1997;99-105.
59. Shea T.B., Beermann M.L. Stauroporine-induced morphological differentiation of human neuroblastoma cells. Cell. Biol. Int. Rep. 15:1991;161-168.
60. Shea T.B., Beermann M.L., Leli U., Nixon R.A. Opposing influences of protein kinase activities on neurite outgrowth in human neuroblastoma cells: initiation by kinase A, restriction by kinase C. J. Neurosci. Res. 33:1992;398-407.
61. Shea T.B., Beermann M.L., Griffin W.R., Leli U. Degradation of protein kinase C alpha and its free catalytic subunit, protein kinase M, in intact human neuroblastoma cells and under cell-free conditions. Evidence that PKM is degraded by mM calpain-mediated proteolysis at a faster rate than PKC. FEBS Lett. 350:1994;223-229.
62. Shea T.B., Beermann M.L., Spencer M.A., Nixon R.A. Enhancement of neurite outgrowth following calpain inhibition is mediated by protein kinase C. J. Neurochem. 65:1995;517-527.
63. Shea T.B., Klinger E.P., Cressman C.M. Calcium influx recruits an additional class of kinases to hyperphosphorylate tau. Neuroreport. 6:1995;1437-1440.
64. T.B. Shea, J.J. Boyce, C.M. Cressman, Potential role of hyperactivation of signal transduction pathways in Alzheimer's disease: Protein kinase C regulates PHF-like phosphorylation of tau within neuronal cells. Thearapies and Emerging Strategies: Proceedings of the XV Washington Spring Symposium on Neurodegenerative Diseases. Plenum, 1995, pp. 447-467.
65. Shea T.B., Fischer I. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules. FEBS Lett. 380:1996;63-67.
66. Shea T.B., Spencer M.J., Beermann M.L., Cressman C.M., Nixon R.A. Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J. Neurochem. 66:1996;1539-1549.
67. Shea T.B., Parabhakar S., Ekinci F.J. β-amyloid and ionophore-mediated calcium influx evoke neurodegeneration by distinct intracellular pathways: differential involvement of the calpain/protein kinase C system. J. Neurosci. Res. 49:1997;759-768.
68. Shea T.B., Didier M. Biphasic effects of phosphatase inhibition on accumulation of tau phospho-isoforms in cultured cerebellar neurons. Neurosci. Res. Commun. 22:1997;39-44.
69. T.B. Shea, F.J. Ekinci, Biphasic influence of calcium influx on tau phosphorylation: involvement of calcium-dependent phosphatases and kinases. J Alzheimer's disease, 1999, in press.
70. Shea T.B., Cressman C.M. The order of exposure of tau to signal transduction kinases alters the generation of "AD-like" phospho-epitopes. Cell. Mol. Neurobiol. 19:1999;224-235.
71. Singh T.J., Zaidi T., Grundke-Iqbal I., Iqbal K. Modulation of GSK-3 catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases. FEBS. 358:1994;4-8.
72. Singh T.J., Haque N., Grundke-Iqbal I., Iqbal K. Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline dependent kinases and GSK-3. FEBS Lett. 358:1994;267-272.
73. Stumpo D.J., Haupt D.M., Blackshear P.J. Protein kinase C isozyme distribution and down-regulation in relation to insulin-stimulated c-fos induction. J. Biol. Chem. 269:1994;21184-21190.
74. Tanaka T., Iqbal K., Trenkner E., Liu D.J., Grundke-Iqbal I. Abnormally phosphorylated tau in SY5Y human neuroblastoma cells. FEBS Lett. 360:1995;5-9.
75. Trojanowski J.Q., Schmidt M.L., Shin R.-W., Bramblett G.T., Rao D., Lee V.M.-Y., Altered tau and neurofilament proteins in neurodegenative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. (1993a) 45-54.
76. Trojanowski J.Q., Schmidt M.L., Shin R.-W., Bramblett G.T., Goedert M., Lee V.M.-Y. PHF tau (A68): from pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin. Neurosci. 1:1993;184-191.
77. Tsuda M., Ono K., Katayama N., Yamagata Y., Kikuchi K., Tsuchiya T. Neurite outgrowth from mouse neuroblastoma and cerebellar cells induced by the protein kinase inhibitor H-7. Neurosci. Lett. 105:1989;241-245.
78. 2+ channels: a possible involvement of free radicals. J. Neurochem. 68:1997;265-271.
79. Vitto A., Nixon R.A. Calcium-activated neutral proteinase of human brain: subunit structure and enzymatic properties of multiple molecular forms. J. Neurochem. 47:1986;1039-1051.